Detalhe da pesquisa
1.
Magnetic resonance imaging targeted biopsy in biopsy-naïve patients and the risk of overtreatment in prostate cancer: a grading issue.
BJU Int;
133(4): 432-441, 2024 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37943114
2.
Predicting the risk of failed trial without catheter following Rezum™ therapy.
World J Urol;
42(1): 129, 2024 Mar 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38460028
3.
Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study.
World J Urol;
42(1): 247, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38647728
4.
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
World J Urol;
42(1): 372, 2024 Jun 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38866949
5.
The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
World J Urol;
42(1): 322, 2024 May 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38747982
6.
Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.
Prostate;
83(2): 162-168, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36259316
7.
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Prostate;
83(6): 572-579, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36705314
8.
Teaching robotic cystectomy: prospective pilot clinical validation of the ERUS training curriculum.
BJU Int;
132(1): 84-91, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36815233
9.
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of core number and location.
World J Urol;
41(6): 1519-1525, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37010577
10.
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.
World J Urol;
41(1): 77-84, 2023 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36509932
11.
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach.
World J Urol;
41(5): 1301-1308, 2023 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36920491
12.
CAR-T Cell Therapy for Solid Tumors: Are we Still That Far? a Systematic Review of Literature.
Cancer Invest;
40(10): 923-937, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36102932
13.
Pathological features of Prostate Imaging Reporting and Data System (PI-RADS) 3 MRI lesions in biopsy and radical prostatectomy specimens.
BJU Int;
129(5): 621-626, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34358405
14.
Uncovering the role of urinary microbiota in urological tumors: a systematic review of literature.
World J Urol;
40(4): 951-964, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34997296
15.
Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?
World J Urol;
40(10): 2423-2429, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35980449
16.
The Virtue quadratic male sling for postradical prostatectomy urinary incontinence: 3-Year outcome measurements and a predictive model of surgical outcome from a European prospective observational study.
Neurourol Urodyn;
41(1): 456-467, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34888939
17.
[Prostate cancer, androgen deprivation, and risk of COVID-19 infection : A systematic review and meta-analysis]. / Cancer de Prostate, déprivation androgénique, et risques d'infection par la COVID-19 : revue systématique et méta-analyse.
Prog Urol;
32(16): 1421-1430, 2022 Dec.
Artigo
em Francês
| MEDLINE
| ID: mdl-36163317
18.
Antibodies targeting Prostate-Specific Membrane Antigen positive prostate cancer: from diagnostic imaging to theranostics.
Curr Opin Oncol;
33(5): 500-506, 2021 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34230440
19.
Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial).
BMC Cancer;
21(1): 1292, 2021 Dec 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34856936
20.
Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
BJU Int;
127(3): 318-325, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32869940